相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis
Bonnie Bengtsson et al.
LIVER INTERNATIONAL (2019)
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study
Samer Gawrieh et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease
Luis Calzadilla Bertot et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017Part 1: Definition, risk factors and assessment
Vincent Wai-Sun Wong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
Mark Thursz et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
Chung-Kwe Wang
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2018)
Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance
X. -J. Kuang et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal et al.
GASTROENTEROLOGY (2018)
Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update
Gamal Shiha et al.
HEPATOLOGY INTERNATIONAL (2017)
Comparison of Laboratory Tests, Ultrasound, or Magnetic Resonance Elastography to Detect Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Guangqin Xiao et al.
HEPATOLOGY (2017)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Clinical Patterns of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease: A Multicenter Prospective Study
Fabio Piscaglia et al.
HEPATOLOGY (2016)
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
Elisabetta Degasperi et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States From 2004 to 2009
Zobair M. Younossi et al.
HEPATOLOGY (2015)
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study
Alessandro Vitale et al.
JOURNAL OF HEPATOLOGY (2015)
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Joong-Won Park et al.
LIVER INTERNATIONAL (2015)
Surveillance, Diagnosis, Treatment, and Outcome of Liver Cancer in Japan
Masatoshi Kudo
LIVER CANCER (2015)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma
J. S. -W. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai-I Yang et al.
LANCET ONCOLOGY (2011)
Prognostic Value of Ishak Fibrosis Stage: Findings from the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
James E. Everhart et al.
HEPATOLOGY (2010)
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
Ying-Chun Shen et al.
JOURNAL OF HEPATOLOGY (2010)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Management of Obesity in Adults: European Clinical Practice Guidelines
Constantine Tsigos et al.
OBESITY FACTS (2008)
Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: Analysis of 5,613 cases from a medical center in southern Taiwan
Kwong-Ming Kee et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
分享论文
